BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Higuchi R, Ota T, Araida T, Kajiyama H, Yazawa T, Furukawa T, Yoshikawa T, Takasaki K, Yamamoto M. Surgical approaches to advanced gallbladder cancer : a 40-year single-institution study of prognostic factors and resectability. Ann Surg Oncol. 2014;21:4308-4316. [PMID: 25023547 DOI: 10.1245/s10434-014-3885-1] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 4.6] [Reference Citation Analysis]
Number Citing Articles
1 Higuchi R, Ono H, Matsuyama R, Takemura Y, Kobayashi S, Otsubo T, Abe Y, Endo I, Tanabe M, Yamamoto M; Association for Clinical Research on Surgery Group (ACRoS1406). Examination of the characteristics of long-term survivors among patients with gallbladder cancer with liver metastasis who underwent surgical treatment: a retrospective multicenter study (ACRoS1406). BMC Gastroenterol 2022;22. [DOI: 10.1186/s12876-022-02234-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Feo CF, Ginesu GC, Fancellu A, Perra T, Ninniri C, Deiana G, Scanu AM, Porcu A. Current management of incidental gallbladder cancer: A review. International Journal of Surgery 2022;98:106234. [DOI: 10.1016/j.ijsu.2022.106234] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Naveed S, Qari H, Thau CM, Burasakarn P, Mir AW. Neoadjuvant Chemotherapy for Advanced Gallbladder Cancer: Do We have Enough Evidence? A Systematic Review. Euroasian J Hepatogastroenterol 2021;11:87-94. [PMID: 34786362 DOI: 10.5005/jp-journals-10018-1348] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
4 Yang Z, Ren T, Liu S, Cai C, Gong W, Shu Y. Preoperative serum fibrinogen as a valuable predictor in the nomogram predicting overall survival of postoperative patients with gallbladder cancer. J Gastrointest Oncol 2021;12:1661-72. [PMID: 34532118 DOI: 10.21037/jgo-21-357] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Zhu J, Hu W, Zhang Y, Du P, Xiao W, Li Y. Comparison of Survival Outcomes of Chemotherapy Plus Surgery vs Chemotherapy Alone for Patients With Isolated Liver Metastases From Gallbladder Carcinoma. Am Surg 2021;:31348211038563. [PMID: 34382879 DOI: 10.1177/00031348211038563] [Reference Citation Analysis]
6 Nagino M, Hirano S, Yoshitomi H, Aoki T, Uesaka K, Unno M, Ebata T, Konishi M, Sano K, Shimada K, Shimizu H, Higuchi R, Wakai T, Isayama H, Okusaka T, Tsuyuguchi T, Hirooka Y, Furuse J, Maguchi H, Suzuki K, Yamazaki H, Kijima H, Yanagisawa A, Yoshida M, Yokoyama Y, Mizuno T, Endo I. Clinical practice guidelines for the management of biliary tract cancers 2019: The 3rd English edition. J Hepatobiliary Pancreat Sci 2021;28:26-54. [PMID: 33259690 DOI: 10.1002/jhbp.870] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 15.0] [Reference Citation Analysis]
7 Matsukuma S, Nagano H, Kobayashi S, Wada H, Seo S, Tsugawa D, Okuyama H, Iida K, Ohmura Y, Takeda Y, Miyamoto A, Nakashima S, Yamada T, Ajiki T, Tsuji A, Yoshimura K, Eguchi H, Hatano E, Ioka T; Kansai Hepato-Biliary Oncology (KHBO) Group. The impact of peritoneal lavage cytology in biliary tract cancer (KHBO1701): Kansai Hepato-Biliary Oncology Group. Cancer Rep (Hoboken) 2021;4:e1323. [PMID: 33283475 DOI: 10.1002/cnr2.1323] [Reference Citation Analysis]
8 Kamada Y, Hori T, Yamamoto H, Harada H, Yamamoto M, Yamada M, Yazawa T, Tani M, Sato A, Tani R, Aoyama R, Sasaki Y, Zaima M. Surgical treatment of gallbladder cancer: An eight-year experience in a single center. World J Hepatol 2020; 12(9): 641-660 [PMID: 33033570 DOI: 10.4254/wjh.v12.i9.641] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Yang XW, Chen JY, Wen ZJ, Li YL, Wang FY, Li L, Yang J, Yang PH, Zhang BH, Shen F. Effect of preoperative jaundice on long-term prognosis of gallbladder carcinoma with radical resection. World J Surg Oncol 2020;18:239. [PMID: 32891147 DOI: 10.1186/s12957-020-02015-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
10 Zhang R, Wu YH, Cai ZQ, Xue F, Zhang D, Chen C, Li Q, Fu JL, Tang ZH, Si SB, Geng ZM. Optimal number of harvested lymph nodes for curatively resected gallbladder adenocarcinoma based on a Bayesian network model. J Surg Oncol 2020;122:1409-17. [PMID: 32820544 DOI: 10.1002/jso.26168] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Higuchi R, Yazawa T, Uemura S, Matsunaga Y, Ota T, Araida T, Furukawa T, Yamamoto M. Examination of Prognostic Factors Affecting Long-Term Survival of Patients with Stage 3/4 Gallbladder Cancer without Distant Metastasis. Cancers (Basel) 2020;12:E2073. [PMID: 32726993 DOI: 10.3390/cancers12082073] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
12 Uemura S, Higuchi R, Yazawa T, Izumo W, Otsubo T, Yamamoto M. Level of total bilirubin in the bile of the future remnant liver of patients with obstructive jaundice undergoing hepatectomy predicts postoperative liver failure. J Hepatobiliary Pancreat Sci 2020;27:614-21. [PMID: 32506707 DOI: 10.1002/jhbp.784] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
13 Noji T, Nagayama M, Imai K, Kawamoto Y, Kuwatani M, Imamura M, Okamura K, Kimura Y, Hirano S. Conversion surgery for initially unresectable biliary malignancies: a multicenter retrospective cohort study. Surg Today 2020;50:1409-17. [PMID: 32468112 DOI: 10.1007/s00595-020-02031-5] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
14 Chen C, Wang L, Zhang R, Li Q, Zhao YL, Zhang GJ, Li WZ, Geng ZM. Who benefits from R0 resection? A single-center analysis of patients with stage Ⅳ gallbladder cancer. Chronic Dis Transl Med 2019;5:188-96. [PMID: 31891130 DOI: 10.1016/j.cdtm.2019.08.004] [Reference Citation Analysis]
15 Geng ZM, Cai ZQ, Zhang Z, Tang ZH, Xue F, Chen C, Zhang D, Li Q, Zhang R, Li WZ, Wang L, Si SB. Estimating survival benefit of adjuvant therapy based on a Bayesian network prediction model in curatively resected advanced gallbladder adenocarcinoma. World J Gastroenterol 2019; 25(37): 5655-5666 [PMID: 31602165 DOI: 10.3748/wjg.v25.i37.5655] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
16 Mizuno T, Ebata T, Nagino M. Author response to comment on: Major hepatectomy with or without pancreatoduodenectomy for advanced gallbladder cancer. Br J Surg 2019;106:1101-2. [PMID: 31260587 DOI: 10.1002/bjs.11237] [Reference Citation Analysis]
17 Choi SY, Kim JH, Park HJ, Han JK. Preoperative CT findings for prediction of resectability in patients with gallbladder cancer. Eur Radiol. 2019;29:6458-6468. [PMID: 31254061 DOI: 10.1007/s00330-019-06323-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
18 Leigh NL, Solomon D, Feingold D, Hiotis SP, Labow DM, Magge DR, Sarpel U, Golas BJ. Staging gallbladder cancer with lymphadenectomy: the practical application of new AHPBA and AJCC guidelines. HPB (Oxford) 2019;21:1563-9. [PMID: 31010632 DOI: 10.1016/j.hpb.2019.03.372] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
19 Mizuno T, Ebata T, Yokoyama Y, Igami T, Yamaguchi J, Onoe S, Watanabe N, Ando M, Nagino M. Major hepatectomy with or without pancreatoduodenectomy for advanced gallbladder cancer. Br J Surg. 2019;106:626-635. [PMID: 30762874 DOI: 10.1002/bjs.11088] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
20 Hakeem AR, Papoulas M, Menon KV. The role of neoadjuvant chemotherapy or chemoradiotherapy for advanced gallbladder cancer – A systematic review. European Journal of Surgical Oncology 2019;45:83-91. [DOI: 10.1016/j.ejso.2018.08.020] [Cited by in Crossref: 17] [Cited by in F6Publishing: 24] [Article Influence: 5.7] [Reference Citation Analysis]
21 Nakada S, Kuboki S, Nojima H, Yoshitomi H, Furukawa K, Takayashiki T, Takano S, Miyazaki M, Ohtsuka M. Roles of Pin1 as a Key Molecule for EMT Induction by Activation of STAT3 and NF-κB in Human Gallbladder Cancer. Ann Surg Oncol 2019;26:907-17. [PMID: 30610554 DOI: 10.1245/s10434-018-07132-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 3.7] [Reference Citation Analysis]
22 Chaudhary RK, Higuchi R, Yazawa T, Uemura S, Izumo W, Furukawa T, Kiyohara K, Yamamoto M. Surgery in node-positive gallbladder cancer: The implication of an involved superior retro-pancreatic lymph node. Surgery 2019;165:541-7. [PMID: 30348459 DOI: 10.1016/j.surg.2018.09.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
23 Dasari BVM, Ionescu MI, Pawlik TM, Hodson J, Sutcliffe RP, Roberts KJ, Muiesan P, Isaac J, Marudanayagam R, Mirza DF. Outcomes of surgical resection of gallbladder cancer in patients presenting with jaundice: A systematic review and meta-analysis. J Surg Oncol. 2018;118:477-485. [PMID: 30259519 DOI: 10.1002/jso.25186] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
24 Kishi Y, Nara S, Esaki M, Hiraoka N, Shimada K. Extent of lymph node dissection in patients with gallbladder cancer. British Journal of Surgery 2018;105:1658-64. [DOI: 10.1002/bjs.10913] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
25 Lim JH, Chong JU, Kim SH, Park SW, Choi JS, Lee WJ, Kim KS. Role of common bile duct resection in T2 and T3 gallbladder cancer patients. Ann Hepatobiliary Pancreat Surg. 2018;22:42-51. [PMID: 29536055 DOI: 10.14701/ahbps.2018.22.1.42] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
26 Cong LL, Cai ZQ, Guo P, Chen C, Liu DC, Li WZ, Wang L, Zhao Y, Si SB, Geng ZM. Decision of surgical approach for advanced gallbladder adenocarcinoma based on a Bayesian network. J Surg Oncol 2017;116:1123-31. [PMID: 28876457 DOI: 10.1002/jso.24797] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
27 Bo X, Wang J, Fu Q, Wang Y, Liu H, Xu J. Stathmin 1 expression predicts prognosis and benefits from adjuvant chemotherapy in patients with gallbladder carcinoma. Oncotarget 2017;8:108548-55. [PMID: 29312550 DOI: 10.18632/oncotarget.19625] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
28 Sakata J, Kobayashi T, Tajima Y, Ohashi T, Hirose Y, Takano K, Takizawa K, Miura K, Wakai T. Relevance of Dissection of the Posterior Superior Pancreaticoduodenal Lymph Nodes in Gallbladder Carcinoma. Ann Surg Oncol 2017;24:2474-81. [PMID: 28653160 DOI: 10.1245/s10434-017-5939-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
29 Sakata J, Kobayashi T, Ohashi T, Hirose Y, Takano K, Takizawa K, Miura K, Ishikawa H, Toge K, Yuza K, Soma D, Ando T, Wakai T. Prognostic heterogeneity of the seventh edition of UICC Stage III gallbladder carcinoma: Which patients benefit from surgical resection? European Journal of Surgical Oncology (EJSO) 2017;43:780-7. [DOI: 10.1016/j.ejso.2017.01.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
30 Sternby Eilard M, Lundgren L, Cahlin C, Strandell A, Svanberg T, Sandström P. Surgical treatment for gallbladder cancer - a systematic literature review. Scand J Gastroenterol 2017;52:505-14. [PMID: 28270039 DOI: 10.1080/00365521.2017.1284895] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 5.8] [Reference Citation Analysis]
31 Chen C, Geng Z, Shen H, Song H, Zhao Y, Zhang G, Li W, Ma L, Wang L. Long-Term Outcomes and Prognostic Factors in Advanced Gallbladder Cancer: Focus on the Advanced T Stage. PLoS One 2016;11:e0166361. [PMID: 27846279 DOI: 10.1371/journal.pone.0166361] [Cited by in Crossref: 34] [Cited by in F6Publishing: 39] [Article Influence: 5.7] [Reference Citation Analysis]
32 Yang G, Zhang L, Li R, Wang L. The role of microRNAs in gallbladder cancer. Mol Clin Oncol. 2016;5:7-13. [PMID: 27330755 DOI: 10.3892/mco.2016.905] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
33 Viganò L, Birnbaum DJ. Reply to: "Gallbladder cancer: Nihilism abates, optimism prevails". Eur J Surg Oncol 2015;41:1444-5. [PMID: 26233820 DOI: 10.1016/j.ejso.2015.07.007] [Reference Citation Analysis]
34 Ohtsuka M, Miyakawa S, Nagino M, Takada T, Miyazaki M. Revision concepts and distinctive points of the new Japanese classification for biliary tract cancers in comparison with the 7 th edition of the Union for International Cancer Control and the American Joint Committee on Cancer staging system: ▪. J Hepatobiliary Pancreat Sci 2015;22:197-201. [DOI: 10.1002/jhbp.212] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]